Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Arsenic Trioxide × Clear all

Phase

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Leukemia, Promyelocytic, Acute 6 Leukemia, Myeloid, Acute 4 Recurrence 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Refractory Solid Tumors 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

Exercise 15 Drug Therapy 15 Capecitabine 10 Blood Specimen Collection 10 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Cyclophosphamide 5 Cisplatin 5 atezolizumab 4 Therapeutics 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4 Injections 4 Gemcitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695223 2021-01-06

Arsenic Trioxide for Structural p53 Mutations

Shanghai Changzheng Hospital

Phase 2 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡